Elevat3 Capital

Investment focus

Sectors

From firm website, not verified

Investment Stages

From firm website, not verified

Geographic Focus

Europe

Inferred thesis

Auto-generated from public data. Not the firm's stated position.

Elevat3 Capital appears to focus on early-stage (Series A–B) European companies across diverse sectors including agritech, biotech, and cleantech, with typical check sizes around €3M, though recent portfolio activity suggests broader interest in digital consumer and B2B platforms beyond disclosed sector categories.

Generated 6 Aug 2026 from disclosed sectors, stages, and portfolio companies. Firms can update this by emailing [email protected].

Typical check size

How To Pitch Elevat3 Capital

No Stated Policy
Elevat3 Capital hasn't published an outreach policy. A short, specific cold email is the safest default.

Who To Contact

Christian Angermayer
Co-Founder & General Partner
Life Sciences
FinTech
Crypto
Future Tech
Dr. Marlon Braumann
Co-Founder & General Partner
Life Sciences
FinTech
Crypto
Future Tech

Portfolio highlights

Clark - digital insurance
Grover - device subscriptions
SellerX - e-commerce rollup

Team

Auto-detected from Elevat3 Capital's website.

Christian Angermayer
Co-Founder & General Partner

Serial entrepreneur and investor, founder of Elevat3 Capital and Apeiron Investment Group.

Life Sciences
FinTech
Crypto
Future Tech
Checked Aug 2026
Dr. Marlon Braumann
Co-Founder & General Partner

Co-founder and general partner focused on venture investments across Europe.

Life Sciences
FinTech
Crypto
Future Tech
Checked Aug 2026
Thomas Hanke
Co-Founder & General Partner

Co-founder and general partner at Elevat3 Capital.

Life Sciences
FinTech
Crypto
Future Tech
Checked Aug 2026

Website reachable as of Aug 2026. Focus and check size as listed by the firm, not independently verified.

Ready To Reach Elevat3 Capital?

A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.